Literature DB >> 7136516

The pathology of Machado-Joseph disease. Report of a possible homozygous case.

P Coutinho, A Guimarães, F Scaravilli.   

Abstract

The clinical and pathological findings in a boy suffering from Machado-Joseph disease are described. The patient was the son of two affected parents and signs first appeared at the age of 8 years. A younger brother also became affected at the age of 7. The patient presented all the characteristic features of the disease which consist of progressive cerebellar ataxia, pyramidal signs, progressive external ophthalmoplegia with variable degrees of extrapyramidal and peripheral signs. He died at the age of 15, after an unusually short duration of the disease. Pathological examination showed degeneration and mild gliosis of the substantia nigra, dentate, pontine and cranial nerve nuclei, anterior horns and Clarke's columns. Additional findings, not previously described were the involvement of sensory ganglia, intermediolateral columns and gracile and cuneate nuclei. It is suggested that the present case is homozygous for the gene of Machado-Joseph disease. The pattern of distribution of the pathological lesions and the sparing of some anatomical structures confirm our view that Machado-Joseph disease should be considered a distinct clinico-pathological entity within the group of the autosomal dominant ataxias.

Entities:  

Mesh:

Year:  1982        PMID: 7136516     DOI: 10.1007/bf00692697

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  13 in total

1.  The Babinski response: a review and new observations.

Authors:  P W NATHAN; M C SMITH
Journal:  J Neurol Neurosurg Psychiatry       Date:  1955-11       Impact factor: 10.154

2.  [Not Available].

Authors:  D LOUIS-BAR; L VAN BOGAERT
Journal:  Monatsschr Psychiatr Neurol       Date:  1947

3.  Azorean disease of the nervous system.

Authors:  F C Romanul; H L Fowler; J Radvany; R G Feldman; M Feingold
Journal:  N Engl J Med       Date:  1977-06-30       Impact factor: 91.245

4.  Nigro-spino-dentatal degeneration with nuclear ophthalmoplegia. A unique and partially treatable clinico-pathological entity.

Authors:  B T Woods; H H Schaumburg
Journal:  J Neurol Sci       Date:  1972-10       Impact factor: 3.181

5.  Machado disease. A hereditary ataxia in Portuguese emigrants to Massachusetts.

Authors:  K K Nakano; D M Dawson; A Spence
Journal:  Neurology       Date:  1972-01       Impact factor: 9.910

6.  Spino-pontine degeneration.

Authors:  F Boller; J M Segarra
Journal:  Eur Neurol       Date:  1969       Impact factor: 1.710

7.  Dominant spino-pontine atrophy. Report of a family through three generations.

Authors:  R Taniguchi; B W Konigsmark
Journal:  Brain       Date:  1971       Impact factor: 13.501

8.  Clinical criteria for diagnosis of Machado-Joseph disease: report of a non-Azorena Portuguese family.

Authors:  L Lima; P Coutinho
Journal:  Neurology       Date:  1980-03       Impact factor: 9.910

9.  Presumably Azorean disease in a presumably non-Portuguese family.

Authors:  E B Healton; J C Brust; D L Kerr; S Resor; A Penn
Journal:  Neurology       Date:  1980-10       Impact factor: 9.910

10.  Autosomal dominant system degeneration in Portuguese families of the Azores Islands. A new genetic disorder involving cerebellar, pyramidal, extrapyramidal and spinal cord motor functions.

Authors:  P Coutinho; C Andrade
Journal:  Neurology       Date:  1978-07       Impact factor: 9.910

View more
  13 in total

1.  Parametric fMRI of paced motor responses uncovers novel whole-brain imaging biomarkers in spinocerebellar ataxia type 3.

Authors:  João Valente Duarte; Ricardo Faustino; Mercês Lobo; Gil Cunha; César Nunes; Carlos Ferreira; Cristina Januário; Miguel Castelo-Branco
Journal:  Hum Brain Mapp       Date:  2016-06-07       Impact factor: 5.038

2.  Chinese homozygous Machado-Joseph disease (MJD)/SCA3: a case report.

Authors:  Sheng Zeng; Junsheng Zeng; Miao He; Xianfeng Zeng; Yao Zhou; Zhen Liu; Hong Jiang; Beisha Tang; Junling Wang
Journal:  J Hum Genet       Date:  2015-01-08       Impact factor: 3.172

3.  Mosaicism of the CAG repeat in CNS tissue in relation to age at death in spinocerebellar ataxia type 1 and Machado-Joseph disease patients.

Authors:  P Maciel; I Lopes-Cendes; S Kish; J Sequeiros; G A Rouleau
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

4.  Homozygosity for Machado-Joseph disease gene enhances phenotypic severity.

Authors:  G Sobue; M Doyu; N Nakao; N Shimada; T Mitsuma; H Maruyama; S Kawakami; S Nakamura
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

5.  Delirium associated with Joseph disease.

Authors:  Y Fukutani; K Katsukawa; R Matsubara; K Kobayashi; I Nakamura; N Yamaguchi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-11       Impact factor: 10.154

6.  Pontine atrophy precedes cerebellar degeneration in spinocerebellar ataxia 7: MRI-based volumetric analysis.

Authors:  O Y Bang; P H Lee; S Y Kim; H J Kim; K Huh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-10       Impact factor: 10.154

7.  Correlation between CAG repeat length and clinical features in Machado-Joseph disease.

Authors:  P Maciel; C Gaspar; A L DeStefano; I Silveira; P Coutinho; J Radvany; D M Dawson; L Sudarsky; J Guimarães; J E Loureiro
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

8.  The peripheral neuropathy in Machado-Joseph disease.

Authors:  P Coutinho; A Guimarães; M M Pires; F Scaravilli
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

9.  Regional cerebral blood flow measured with N-isopropyl-p-[123I]iodoamphetamine single-photon emission tomography in patients with Joseph disease.

Authors:  N Takahashi; I Odano; M Nishihara; T Yuasa; K Sakai
Journal:  Eur J Nucl Med       Date:  1994-07

10.  ULK overexpression mitigates motor deficits and neuropathology in mouse models of Machado-Joseph disease.

Authors:  Ana Vasconcelos-Ferreira; Inês Morgado Martins; Diana Lobo; Dina Pereira; Miguel M Lopes; Rosário Faro; Sara M Lopes; Dineke Verbeek; Thorsten Schmidt; Clévio Nóbrega; Luís Pereira de Almeida
Journal:  Mol Ther       Date:  2021-07-21       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.